Seiji M.

Seiji M. is a Partner and Senior Investment Director at Taiho Ventures, LLC, holding various positions within the firm since July 2016. Seiji also serves as a Board Member for EpiBiologics and hC Bioscience, Inc., while acting as a Board Observer for Transition Bio, Inc., Anavo Therapeutics BV, Theolytics, and Breakpoint Therapeutics GmbH. Prior to Taiho Ventures, Seiji was a Research Fellow at Taiho Pharmaceutical Co., Ltd. from April 2004 to July 2016. Seiji holds a Doctor of Philosophy (PhD) in Life Science from Hokkaido University.